---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-031978"
form_type: "8-K/A"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:50:54.072175+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Reviva Pharmaceuticals completes auditor change to Moss Adams LLP effective Nov 14, 2023

## Summary
- Armanino LLP's engagement ended Nov 14, 2023 after completing Q3 2023 review; Moss Adams LLP engaged same day.
- Armanino's 2022 audit report included a going concern explanatory paragraph; no disagreements or reportable events.
- Moss Adams was not consulted on accounting principles or audit opinion prior to engagement.
- Auditor change previously disclosed Oct 4, 2023; this amendment adds effective date.

## SEC filing metadata
- accession: 0001437749-23-031978
- form_type: 8-K/A
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774923031978/0001437749-23-031978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774923031978/rvph20231108_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-031978
- JSON: https://secwatch.observer/filing/0001437749-23-031978.json
- Plain text: https://secwatch.observer/filing/0001437749-23-031978.txt

## Key facts
- Auditor Changes
  REVIVA PHARMACEUTICALS HOLDINGS, INC. engaged Moss Adams LLP as its auditor.
  - Action: engagement
  - Auditor: Moss Adams LLP
  source text: On November 14, 2023, Moss Adams LLP’s engagement as the Company’s new independent registered public accounting firm commenced and became effective.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1742927/000143774923031978/0001437749-23-031978-index.htm
- Auditor Changes
  REVIVA PHARMACEUTICALS HOLDINGS, INC. dismissed Armanino LLP as its auditor.
  - Action: dismissal
  - Auditor: Armanino LLP
  - Successor: Moss Adams LLP
  source text: In light of Armanino LLP’s determination, the Audit Committee of the Company’s Board of Directors initiated a process to select a new accounting firm to serve as the Company’s independent registered public accountant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1742927/000143774923031978/0001437749-23-031978-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.